BBHC
ONC

Brown Brothers Harriman & Co’s BeOne Medicines Ltd ONC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2K Hold
57
– – ﹤0.01% 1332
2026
Q1 		$16.9K Sell
57
-70
-55% -$22.7K ﹤0.01% 1255
2025
Q4 		$38.6K Buy
127
+88
+226% +$28.8K ﹤0.01% 1085
2025
Q3 		$13.3K Sell
39
-6
-13% -$1.82K ﹤0.01% 1243
2025
Q2 		$10.9K Hold
45
– – ﹤0.01% 1184
2025
Q1 		$12.2K Hold
45
– – ﹤0.01% 1036
2024
Q4 		$8.31K Buy
45
+42
+1,400% +$8.58K ﹤0.01% 1152
2024
Q3 		$674 Buy
+3
New +$540 ﹤0.01% 1363
2023
Q4 		– Sell
-6
Closed -$1.08K – 1293
2023
Q3 		$1.08K Buy
+6
New +$1.19K ﹤0.01% 1144
2023
Q2 		– Sell
-22
Closed -$4.74K – 1351
2023
Q1 		$4.74K Buy
+22
New +$5.28K ﹤0.01% 1072
2022
Q4 		– Sell
-3
Closed – – 1529
2022
Q3 		$0 Sell
3
-132
-98% -$22.7K ﹤0.01% 1598
2022
Q2 		$22K Sell
135
-12
-8% -$1.87K ﹤0.01% 866
2022
Q1 		$28K Hold
147
– – ﹤0.01% 875
2021
Q4 		$40K Sell
147
-3
-2% -$1.01K ﹤0.01% 742
2021
Q3 		$54K Hold
150
– – ﹤0.01% 666
2021
Q2 		$51K Hold
150
– – ﹤0.01% 668
2021
Q1 		$52K Buy
150
+135
+900% +$44.7K ﹤0.01% 643
2020
Q4 		$4K Buy
+15
New +$4.13K ﹤0.01% 978
2019
Q3 		– Sell
-425
Closed -$53K – 1302
2019
Q2 		$53K Buy
+425
New +$53.9K ﹤0.01% 580

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Brothers Harriman & Co's ONC Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 57 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

Brown Brothers Harriman & Co first reported a position in ONC in Q2 2019 and has held it in 19 quarters since. The position peaked at $54K in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Brown Brothers Harriman & Co held 57 shares of BeOne Medicines Ltd worth $16.2K as of Q2 2026.
  • Brown Brothers Harriman & Co left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1332 holding.
  • Brown Brothers Harriman & Co first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 19 quarters since.
  • Brown Brothers Harriman & Co's BeOne Medicines Ltd position peaked at $54K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.